ARKG Investment Tracker

Source from:official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 5,016 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 8.58% of the total position.
      91Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 13,168 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2% of the total position.
      7Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 732 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2% of the total position.
      13Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 5,134 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 2.65% of the total position.
      654Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 5,106 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 9.15% of the total position.
      63Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Illumina by 948 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 4.59% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Natera by 588 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 4.56% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 30,348 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 3.9% of the total position.
      6.69K2
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Increased position in 10x Genomics, Inc. by 5,388 shares, the number of shares held increased 0.18% compared to the previous period and now represents 5.4% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 5,370 shares, the number of shares held decreased 0.25% compared to the previous period and now represents 5.16% of the total position.
      34Comment
      Report
       
       
       
       

      Most Discussed